Evidence map›Paper›PMID 35746729›Full record

ArticleViruses2022

Molecular Characterisation and Phylogeny of Tula Virus in Kazakhstan.

Nur Tukhanova, Anna Shin, Nurkeldi Turebekov, Talgat Nurmakhanov, Karlygash Abdiyeva, Alexandr Shevtsov, Toktasyn Yerubaev, Gulnara Tokmurziyeva, Almas Berdibekov, Vitaliy Sutyagin and 10 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 2 countries.

Nur TukhanovaCenter for International Health, University Hospital, Ludwig Maximilians University, 80336 Munich, Germany.
Anna ShinCenter for International Health, University Hospital, Ludwig Maximilians University, 80336 Munich, Germany.
Nurkeldi TurebekovAikimbayev's National Scientific Center for Especially Dangerous Infections, Almaty 050054, Kazakhstan.
Talgat NurmakhanovAikimbayev's National Scientific Center for Especially Dangerous Infections, Almaty 050054, Kazakhstan.
Karlygash AbdiyevaAlmaty Branch National Center for Biotechnology, Almaty 050054, Kazakhstan.
Alexandr ShevtsovNational Center for Biotechnology, Nur Sultan 010000, Kazakhstan.
Toktasyn YerubaevAikimbayev's National Scientific Center for Especially Dangerous Infections, Almaty 050054, Kazakhstan.
Gulnara TokmurziyevaAikimbayev's National Scientific Center for Especially Dangerous Infections, Almaty 050054, Kazakhstan.
Almas BerdibekovTaldykorgan Antiplague Station, Branch Aikimbayev's National Scientific Center for Especially Dangerous Infections, Taldykorgan 040000, Kazakhstan.
Vitaliy SutyaginTaldykorgan Antiplague Station, Branch Aikimbayev's National Scientific Center for Especially Dangerous Infections, Taldykorgan 040000, Kazakhstan.
Nurbek MaikanovOral Antiplague Station, Branch Aikimbayev's National Scientific Center for Especially Dangerous Infections, Oral 09002, Kazakhstan.
Andrei ZakharovOral Antiplague Station, Branch Aikimbayev's National Scientific Center for Especially Dangerous Infections, Oral 09002, Kazakhstan.
Ilmars LezdinshTaldykorgan Antiplague Station, Branch Aikimbayev's National Scientific Center for Especially Dangerous Infections, Taldykorgan 040000, Kazakhstan.ORCID 0000-0002-2457-133X
Lyazzat YeraliyevaNational Scientific Center of Phthisiopulmonology, Almaty 050010, Kazakhstan.ORCID 0000-0002-0892-166X
Guenter FroeschlCenter for International Health, University Hospital, Ludwig Maximilians University, 80336 Munich, Germany.ORCID 0000-0003-2743-7555
Michael HoelscherDivision of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig Maximilians University, 80802 Munich, Germany.ORCID 0000-0002-7642-1835
Stefan FreyBundeswehr Research Institute for Protective Technologies and CBRN Protection, 29633 Munster, Germany.
Edith WagnerSection of Experimental Virology, Institute of Medical Microbiology, Jena University Hospital, 07745 Jena, Germany.ORCID 0000-0003-1720-3923
Lukas PeintnerGerman Centre for Infection Research, Department Virology and Intracellular Agents, Munich Partner Site Bundeswehr Institute of Microbiology, 80937 Munich, Germany.ORCID 0000-0002-0445-1445
Sandra EssbauerGerman Centre for Infection Research, Department Virology and Intracellular Agents, Munich Partner Site Bundeswehr Institute of Microbiology, 80937 Munich, Germany.ORCID 0000-0003-0909-742X
Kazakh Research Institute of Plant Protection and Quarantine · KZGerman Center for Infection Research · DELudwig-Maximilians-Universität München · DENational Center for Biotechnology · KZKazakh Institute of Oncology and Radiology · KZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Orthohantaviruses are zoonotic pathogens that play a significant role in public health. These viruses can cause haemorrhagic fever with renal syndrome in Eurasia. In the Republic of Kazakhstan, the first human cases were registered in the year 2000 in the West Kazakhstan region. Small mammals can be reservoirs of orthohantaviruses. Previous studies showed orthohantavirus antigens in wild-living small mammals in four districts of West Kazakhstan. Clinical studies suggested that there might be further regions with human orthohantavirus infections in Kazakhstan, but genetic data of orthohantaviruses in natural foci are limited. The aim of this study was to investigate small mammals for the presence of orthohantaviruses by molecular biological methods and to provide a phylogenetic characterization of the circulating strains in Kazakhstan. Small mammals were trapped at 19 sites in West Kazakhstan, four in Almaty region and at seven sites around Almaty city during all seasons of 2018 and 2019. Lung tissues of small mammals were homogenized and RNA was extracted. Orthohantavirus RT-PCR assays were applied for detection of partial S and L segment sequences. Results were compared to published fragments. In total, 621 small mammals from 11 species were analysed. Among the collected small mammals, 2.4% tested positive for orthohantavirus RNA, one sample from West Kazakhstan and 14 samples from Almaty region. None of the rodents caught in Almaty city were infected. Sequencing parts of the small (S) and large (L) segments specified Tula virus (TULV) in these two regions. Our data show that geographical distribution of TULV is more extended as previously thought. The detected sequences were found to be split in two distinct genetic clusters of TULV in West Kazakhstan and Almaty region. TULV was detected in the common vole (

Indexed as

Hantavirus InfectionsOrthohantavirusRNA VirusesAnimalsArvicolinaeKazakhstanPhylogenyRNARNAorthohantavirusRepublic of KazakhstanrodentsTula virus

Identifiers

PMID35746729
PMCPMC9230364
OpenAlexW4282843804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.